| Literature DB >> 7664892 |
Abstract
With the available data, deferred treatment is definitely an option for patients with low grade clinically localized prostate cancer if their life expectancy is 10 years or less and avoids the side-effects of treatment. Many patients will avoid the need for therapy of their prostate cancer during their remaining lifetime.Entities:
Mesh：
Year: 1995 PMID： 7664892 DOI： 10.1016/s0748-7983(95)92087-0
Source DB: PubMed Journal: Eur J Surg Oncol ISSN： 0748-7983 Impact factor: 4.424